EdenteV1, Istex, Curation, bibRecord, 000350

NICE is dead; long live NICE

Identifieur interne : 000350 ( Istex/Curation ); précédent : 000349; suivant : 000351

NICE is dead; long live NICE

Auteurs : Krishna Chinthapalli [Royaume-Uni]

Source :

BMJ : British Medical Journal [ 0959-8138 ] ; 2013.

RBID : ISTEX:5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8

Descripteurs français

Wicri :
- topic : Industrie pharmaceutique.

English descriptors

KwdEn :
- April, Beta interferon, Better outcomes, Cancer drugs fund, Chief executive, Clinical excellence, Clinical guidelines, Commons health committee, Cost effectiveness, Cost effectiveness threshold, David haslam, Drug companies, Drug prices, Early breast cancer, Extra increase, Frank dobson, Full compliance, Guideline, Health secretary, Innovation health, Innovation scorecard, Local authorities, Multiple sclerosis risk, National institute, Parveen kumar, Patient groups, Pharmaceutical, Pharmaceutical benefits, Pharmaceutical industry, Qalys, Rawlins, Same time, Social care, Wider benefits.
Teeft :
- April, Beta interferon, Better outcomes, Cancer drugs fund, Chief executive, Clinical excellence, Clinical guidelines, Commons health committee, Cost effectiveness, Cost effectiveness threshold, David haslam, Drug companies, Drug prices, Early breast cancer, Extra increase, Frank dobson, Full compliance, Guideline, Health secretary, Innovation health, Innovation scorecard, Local authorities, Multiple sclerosis risk, National institute, Parveen kumar, Patient groups, Pharmaceutical, Pharmaceutical benefits, Pharmaceutical industry, Qalys, Rawlins, Same time, Social care, Wider benefits.

Abstract

This month sees a new beginning for NICE, with a new chair and legal status. Krishna Chinthapalli assesses what it has achieved and the challenges it faces in the future

Url:

https://api.istex.fr/document/5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8/fulltext/pdf

DOI: 10.1136/bmj.f2546

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000350

Links to Exploration step

ISTEX:5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>NICE is dead; long live NICE</title>
<author wicri:is="90%"><name sortKey="Chinthapalli, Krishna" sort="Chinthapalli, Krishna" uniqKey="Chinthapalli K" first="Krishna" last="Chinthapalli">Krishna Chinthapalli</name>
<affiliation wicri:level="1"><mods:affiliation>1BMJ, London WC1H 9JR, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>1BMJ, London WC1H 9JR</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>kchinthapalli@bmj.com</mods:affiliation>
<wicri:noCountry code="no comma">kchinthapalli@bmj.com</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>E-mail: kchinthapalli@bmj.com</mods:affiliation>
<wicri:noCountry code="no comma">E-mail: kchinthapalli@bmj.com</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1136/bmj.f2546</idno>
<idno type="url">https://api.istex.fr/document/5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000350</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000350</idno>
<idno type="wicri:Area/Istex/Curation">000350</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">NICE is dead; long live NICE</title>
<author wicri:is="90%"><name sortKey="Chinthapalli, Krishna" sort="Chinthapalli, Krishna" uniqKey="Chinthapalli K" first="Krishna" last="Chinthapalli">Krishna Chinthapalli</name>
<affiliation wicri:level="1"><mods:affiliation>1BMJ, London WC1H 9JR, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>1BMJ, London WC1H 9JR</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>kchinthapalli@bmj.com</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: kchinthapalli@bmj.com</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">BMJ : British Medical Journal</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="ISSN">0959-8138</idno>
<idno type="eISSN">1756-1833</idno>
<imprint><publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="2013">2013</date>
<biblScope unit="volume">346</biblScope>
</imprint>
<idno type="ISSN">0959-8138</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0959-8138</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>April</term>
<term>Beta interferon</term>
<term>Better outcomes</term>
<term>Cancer drugs fund</term>
<term>Chief executive</term>
<term>Clinical excellence</term>
<term>Clinical guidelines</term>
<term>Commons health committee</term>
<term>Cost effectiveness</term>
<term>Cost effectiveness threshold</term>
<term>David haslam</term>
<term>Drug companies</term>
<term>Drug prices</term>
<term>Early breast cancer</term>
<term>Extra increase</term>
<term>Frank dobson</term>
<term>Full compliance</term>
<term>Guideline</term>
<term>Health secretary</term>
<term>Innovation health</term>
<term>Innovation scorecard</term>
<term>Local authorities</term>
<term>Multiple sclerosis risk</term>
<term>National institute</term>
<term>Parveen kumar</term>
<term>Patient groups</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical benefits</term>
<term>Pharmaceutical industry</term>
<term>Qalys</term>
<term>Rawlins</term>
<term>Same time</term>
<term>Social care</term>
<term>Wider benefits</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>April</term>
<term>Beta interferon</term>
<term>Better outcomes</term>
<term>Cancer drugs fund</term>
<term>Chief executive</term>
<term>Clinical excellence</term>
<term>Clinical guidelines</term>
<term>Commons health committee</term>
<term>Cost effectiveness</term>
<term>Cost effectiveness threshold</term>
<term>David haslam</term>
<term>Drug companies</term>
<term>Drug prices</term>
<term>Early breast cancer</term>
<term>Extra increase</term>
<term>Frank dobson</term>
<term>Full compliance</term>
<term>Guideline</term>
<term>Health secretary</term>
<term>Innovation health</term>
<term>Innovation scorecard</term>
<term>Local authorities</term>
<term>Multiple sclerosis risk</term>
<term>National institute</term>
<term>Parveen kumar</term>
<term>Patient groups</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical benefits</term>
<term>Pharmaceutical industry</term>
<term>Qalys</term>
<term>Rawlins</term>
<term>Same time</term>
<term>Social care</term>
<term>Wider benefits</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Industrie pharmaceutique</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">This month sees a new beginning for NICE, with a new chair and legal status. Krishna Chinthapalli assesses what it has achieved and the challenges it faces in the future</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV1/Data/Istex/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000350 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000350 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV1
   |flux=    Istex
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8
   |texte=   NICE is dead; long live NICE
}}

This area was generated with Dilib version V0.6.33.
Data generation: Mon Dec 4 11:02:15 2017. Site generation: Tue Sep 29 19:14:38 2020

	Serveur d'exploration sur le patient édenté (maquette)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le patient édenté (maquette)

NICE is dead; long live NICE

NICE is dead; long live NICE

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri